Evaluating the Longevity of the Fontan Pathway.
John M KellyGabriel J M MirhaidariYu-Chun ChangToshiharu ShinokaChristopher K BreuerAndrew R YatesKan N HorPublished in: Pediatric cardiology (2020)
Children born with single ventricle physiology who undergo Fontan palliation face a diverse set of long-term complications. However, patient follow-up has in large part been limited to single institutional experiences without uniform application of diagnostic modalities to screen for relevant outcomes. Additionally, the use of different graft materials and variable surgical technique as part of the Fontan procedure has further complicated the evaluation of single ventricle patients. The purpose of this review is to define the changes in the Fontan pathway specific to the graft material used and its relationship to patient outcomes. As a means of introduction, we briefly review the historical evolution of the Fontan procedure with a focus on the intent behind design changes and incorporation of different biomaterials. We further delineate changes to the Fontan pathway which include the development of stenosis, differential growth, thrombosis, and calcification. Ultimately, the recognition of the changes noted within the Fontan pathway need to be assessed relative to their impact on patient hemodynamics, functional capacity, and Fontan-associated comorbidities.
Keyphrases
- end stage renal disease
- chronic kidney disease
- pulmonary embolism
- case report
- minimally invasive
- ejection fraction
- pulmonary hypertension
- type diabetes
- newly diagnosed
- mental health
- metabolic syndrome
- high throughput
- peritoneal dialysis
- pulmonary arterial hypertension
- preterm birth
- left ventricular
- patient reported
- glycemic control
- bone regeneration